Wilson L, Turner D, Nguyen T
Williams turned to Ro (a company where her husband, Alexis Ohanian, is an investor and board member) to access Zepbound
Whether you choose PlushCare, Ro, or a compounded GLP-1 program through PlexusDx, combining baseline biomarker testing with genetic predisposition insight supports a more personalized conversation with your provider
Biochem J 340:309
Following this spike, switching rates declined but remained elevated through September 2025 at 1.6% on average before returning to an average baseline level of 0.6% between October 2025 and February 2026
[1] Beyond glycemic control, GLP-1 medications slow gastric emptying, which prolongs the feeling of fullness after meals and contributes to reduced caloric intake